Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

12.47
+0.15501.26%
Volume:89.81K
Turnover:1.11M
Market Cap:437.11M
PE:-103.87
High:12.67
Open:12.42
Low:12.13
Close:12.31
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:1.65
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:10.30
PE(LYR):-36.57

Loading ...

Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Major Issues Report

8-K - Current report
Jan 31, 2022

Major Issues Report

8-K - Current report
Oct 21, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 24, 2021

Major Issues Report

8-K - Current report
Jun 22, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 30, 2020

Major Issues Report

8-K - Current report
Sep 21, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Major Issues Report

8-K - Current report